The aims of this study were: (1) To define how YY1 may influence CRC cellular response to anti-cancer treatment and to further identify potential transcriptional targets of YY1 and (2) To evaluate in CRC patients the diagnostic and prognostic potential of the YY1 gene and/or identified transcriptional target(s). This evidence concerns the gene YY1 and colorectal carcinoma.